New research from the University of Tennessee Health Science Center suggests that proposed front-of-package nutrition labels could help Americans better identify healthier foods but may not work equally well for all consumers.
Yuru Huang, PhD, was on a research team that published a study in the American Journal of Preventive Medicine examining the FDA’s proposed front-of-package nutrition label.
A University of Houston scientist has joined a $3.2 million research collaboration to develop a new drug targeting one of the key drivers of triple-negative breast cancer.
A researcher at the University of Houston College of Pharmacy has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease, accounting for 10-15% of all breast cancer cases.
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.
Research targets deadly triple-negative breast cancer
The Maury Regional Health Care Foundation announced appointments to its board of directors for 2026 during the group’s December meeting.
